Literature DB >> 24535226

Evaluation of the thiazole Schiff bases as β-glucuronidase inhibitors and their in silico studies.

Khalid Mohammed Khan1, Aneela Karim, Sumayya Saied, Nida Ambreen, Xayale Rustamova, Shagufta Naureen, Sajid Mansoor, Muhammad Ali, Shahnaz Perveen, M Iqbal Choudhary, Guillermo Antonio Morales.   

Abstract

Twenty eight (28) derivatives 2-29 were synthesized and four analogs were found to exhibit single-digit IC(50) values as β-glucuronidase inhibitors. Molecular modeling indicates that three factors: substituent R, lone pair on the nitrogen of azomethine part, and the interactions made by the main skeleton of the molecule, determined the enzyme inhibitory potential of these compounds. The planar conformation of the molecules allows them to fit deep inside the pocket while blocking the entry of other physiological substrates seems to play an important role in their activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24535226     DOI: 10.1007/s11030-013-9500-8

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  19 in total

Review 1.  The role of beta-glucuronidase in drug disposition and drug targeting in humans.

Authors:  B Sperker; J T Backman; H K Kroemer
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

Review 2.  Neuraminidase inhibitors for influenza.

Authors:  Anne Moscona
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

3.  Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs.

Authors:  Ian Hutchinson; Sharon A Jennings; B Rao Vishnuvajjala; Andrew D Westwell; Malcolm F G Stevens
Journal:  J Med Chem       Date:  2002-01-31       Impact factor: 7.446

4.  3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile derivatives: inhibitors of immune complex induced inflammation.

Authors:  F Haviv; J D Ratajczyk; R W DeNet; F A Kerdesky; R L Walters; S P Schmidt; J H Holms; P R Young; G W Carter
Journal:  J Med Chem       Date:  1988-09       Impact factor: 7.446

Review 5.  Potential use of D-glucaric acid derivatives in cancer prevention.

Authors:  Z Walaszek
Journal:  Cancer Lett       Date:  1990-10-08       Impact factor: 8.679

6.  Phenoxy thiazole derivatives as potent and selective acetyl-CoA carboxylase 2 inhibitors: Modulation of isozyme selectivity by incorporation of phenyl ring substituents.

Authors:  Richard F Clark; Tianyuan Zhang; Xiaojun Wang; Rongqi Wang; Xiaolin Zhang; Heidi S Camp; Bruce A Beutel; Hing L Sham; Yu Gui Gu
Journal:  Bioorg Med Chem Lett       Date:  2007-01-19       Impact factor: 2.823

7.  Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450.

Authors:  C N Hodge; P E Aldrich; L T Bacheler; C H Chang; C J Eyermann; S Garber; M Grubb; D A Jackson; P K Jadhav; B Korant; P Y Lam; M B Maurin; J L Meek; M J Otto; M M Rayner; C Reid; T R Sharpe; L Shum; D L Winslow; S Erickson-Viitanen
Journal:  Chem Biol       Date:  1996-04

8.  N-(4-substituted-thiazolyl)oxamic acid derivatives, a new series of potent, orally active antiallergy agents.

Authors:  K D Hargrave; F K Hess; J T Oliver
Journal:  J Med Chem       Date:  1983-08       Impact factor: 7.446

9.  Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs.

Authors:  F W Bell; A S Cantrell; M Högberg; S R Jaskunas; N G Johansson; C L Jordan; M D Kinnick; P Lind; J M Morin; R Noréen
Journal:  J Med Chem       Date:  1995-12-08       Impact factor: 7.446

10.  Bioinformatics characterization of potential new beta-glucuronidase from Streptococcus equi subsp. zooepidemicus.

Authors:  Ján Krahulec; Tomás Szemes; Jana Krahulcová
Journal:  Mol Biotechnol       Date:  2010-03       Impact factor: 2.695

View more
  3 in total

1.  Facile synthesis and biological assays of novel 2,4-disubstituted hydrazinyl-thiazoles analogs.

Authors:  Fateme Ghanbari Pirbasti; Nosrat O Mahmoodi
Journal:  Mol Divers       Date:  2016-01-11       Impact factor: 2.943

Review 2.  Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.

Authors:  Paul Awolade; Nosipho Cele; Nagaraju Kerru; Lalitha Gummidi; Ebenezer Oluwakemi; Parvesh Singh
Journal:  Eur J Med Chem       Date:  2019-12-04       Impact factor: 6.514

3.  Thiazolidin-2-cyanamides derivatives as novel potent Escherichia coli β-glucuronidase inhibitors and their structure-inhibitory activity relationships.

Authors:  Tao-Shun Zhou; Bin Wei; Min He; Ya-Sheng Li; Ya-Kun Wang; Si-Jia Wang; Jian-Wei Chen; Hua-Wei Zhang; Zi-Ning Cui; Hong Wang
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.